Saturated fatty acid palmitate-induced insulin resistance is accompanied with myotube loss and the impaired expression of health benefit myokine genes in C2C12 myotubes

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Yang, Ming ^a   Wei, Dandan ^a   Mo, Chunfen ^a   Zhang, Jie ^a   Wang, Xu ^a   Han, Xiaojuan ^a   Wang, Zhe ^a   Xiao, Hengyi ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Insulin resistance; Myokine; Myotube loss; Palmitate

Indexed keywords

CYTOKINE; GLUCOSE TRANSPORTER 4; MYOKINE; OLEIC ACID; PALMITIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SATURATED FATTY ACID; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; CTRP15 PROTEIN, MOUSE; FATTY ACID; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21; FIBRONECTIN; FNDC5 PROTEIN, MOUSE; MUSCLE PROTEIN; PALMITIC ACID DERIVATIVE; SLC2A4 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; CTRP15 GENE; ENZYME PHOSPHORYLATION; FGF21 GENE; FNDC5 GENE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE TRANSPORT; INSULIN RESISTANCE; MARKER GENE; MTT ASSAY; MYOTUBE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAINING; TISSUE DIFFERENTIATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL SURVIVAL; CULTURE TECHNIQUE; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; SKELETAL MUSCLE; DRUG EFFECT;

ANIMALS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CYTOKINES; FATTY ACIDS; FIBROBLAST GROWTH FACTORS; FIBRONECTINS; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; INSULIN RESISTANCE; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCLE, SKELETAL; PALMITATES;

EID: 84880183917     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-104     Document Type: Article

References (31)

1. DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991, 14 (3): 173-94. 10.2337/diacare.14.3.173
2. Jove M: Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells. Endocrinology. 2005, 146 (7): 3087-95. 10.1210/en.2004-1560
3. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997, 46 (1): 3-10. 10.2337/diabetes.46.1.3
4. Roden M: Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996, 97 (12): 2859-65. 10.1172/JCI118742
5. Dimopoulos N: Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells. Biochem J. 2006, 399 (3): 473-81. 10.1042/BJ20060244
6. Holland WL: Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 2007, 5 (3): 167-79. 10.1016/j.cmet.2007.01.002
7. Dey D: Involvement of novel PKC isoforms in FFA induced defects in insulin signaling. Mol Cell Endocrinol. 2006, 246 (1-2): 60-4.
8. Yu C: Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 2002, 277 (52): 50230-6. 10.1074/jbc.M200958200
9. Deng YT: Suppression of free fatty acid-induced insulin resistance by phytopolyphenols in C2C12 mouse skeletal muscle cells. J Agric Food Chem. 2012, 60 (4): 1059-66. 10.1021/jf204496f
10. Long YC, Zierath JR: AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest. 2006, 116 (7): 1776-83. 10.1172/JCI29044
11. Brown DM, Parr T, Brameld JM: Myosin heavy chain mRNA isoforms are expressed in two distinct cohorts during C2C12 myogenesis. J Muscle Res Cell Motil. 2012, 32 (6): 383-90. 10.1007/s10974-011-9267-4
12. Vescovo G: Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy. Cardiovasc Res. 1998, 39 (1): 233-41. 10.1016/S0008-6363(98)00041-8
13. Randall WB: Docosahexaenoic acid protects muscle cells from palmitate-induced atrophy. 2012, 10.5402/2012/647348. ISRN Obesity.
14. Fanzani A: Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J Cachexia Sarcopenia Muscle. 2012, 3 (3): 163-79. 10.1007/s13539-012-0074-6
15. Goldbach-Mansky R: Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Clin Exp Immunol. 2012, 167 (3): 391-404. 10.1111/j.1365-2249.2011.04533.x
16. Zhang L: Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J. 2011, 25 (5): 1653-63. 10.1096/fj.10-176917
17. Pedersen BK: The diseasome of physical inactivity-and the role of myokines in muscle-fat cross talk. J Physiol. 2009, 587 (Pt 23): 5559-68.
18. Seldin MM: Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. J Biol Chem. 2012, 287 (15): 11968-80. 10.1074/jbc.M111.336834
19. Bostrom P: A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012, 481 (7382): 463-8. 10.1038/nature10777
20. Kim KH: Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat Med. 2013, 19 (1): 83-92.
21. Cheng Q: Visfatin inhibits apoptosis of pancreatic beta-cell line, MIN6, via the mitogen-activated protein kinase/phosphoinositide 3-kinase pathway. J Mol Endocrinol. 2011, 47 (1): 13-21. 10.1530/JME-10-0106
22. Jove M: Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation. Endocrinology. 2006, 147 (1): 552-61.
23. Li N: D-galactose induces necroptotic cell death in neuroblastoma cell lines. J Cell Biochem. 2011, 112 (12): 3834-44. 10.1002/jcb.23314
24. Zhou Q: Evidence for adipose-muscle cross talk: opposing regulation of muscle proteolysis by adiponectin and Fatty acids. Endocrinology. 2007, 148 (12): 5696-705. 10.1210/en.2007-0183
25. Chavez JA, Summers SA: Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys. 2003, 419 (2): 101-9. 10.1016/j.abb.2003.08.020
26. Wang X: Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology. 2006, 147 (9): 4160-8. 10.1210/en.2006-0251
27. Gaster M, Rustan AC, Beck-Nielsen H: Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes. Diabetes. 2005, 54 (3): 648-56. 10.2337/diabetes.54.3.648
28. Lilienbaum A: Relationship between the proteasomal system and autophagy. Int J Biochem Mol Biol. 2013, 4 (1): 1-26.
29. Sadiq F: Amino acids and insulin act additively to regulate components of the ubiquitin-proteasome pathway in C2C12myotubes. BMC Mol Biol. 2007, 8: 23. 10.1186/1471-2199-8-23
30. Sheng X: Different degree in proteasome malfunction has various effects on root growth possibly through preventing cell division and promoting autophagic vacuolization. PLoS One. 2012, 7 (9): e45673. 10.1371/journal.pone.0045673
31. Kadotani A: Different impacts of saturated and unsaturated free fatty acids on COX-2 expression in C(2)C(12) myotubes. Am J Physiol Endocrinol Metab. 2009, 297 (6): E1291-303. 10.1152/ajpendo.00293.2009